We had such an inspiring time at our Diabetes Consumer Event held at ProGenis Pharmaceuticals on Wednesday, August 20, 2025.
Participants enjoyed learning about our breakthrough RNA therapeutic, PGP-011D, developed for type 2 diabetes, engaging in open discussions with our research and clinical teams, and exploring our dedicated laboratory facility at The Hub, Bentley Technology Park in Perth, Western Australia.
A heartfelt thank you to all the wonderful speakers who made the day so special — Professor Rakesh N. Veedu, Professor Bu Yeap, Dr Vimal Ramachandran, Mr Mani Kutchbothla, and Sophie McGough. Your insights, expertise, and passion truly inspired everyone who attended.
We extend our sincere gratitude to Diabetes WA for your support in helping us connect with consumers and for your ongoing collaboration. Your partnership and encouragement are invaluable as we continue to advance innovative therapies for people living with diabetes.
To all participants — thank you for sharing your stories, questions, and perspectives. Your input drives the work we do every day and strengthens our mission to deliver RNA-based therapeutics that can make a meaningful difference in people’s lives.
We’re also pleased to share an interview with our Clinical Chair, Professor Bu Yeap, one of Western Australia’s leading endocrinologists, discussing the ProGenis Diabetes Program.
If you are living with type 2 diabetes or insulin resistance, we warmly welcome you to join our consumer group — your participation is invaluable in helping us develop better, patient-focused treatments.
The link to the blog on the Diabetes WA website:
https://lnkd.in/ggumQCkF